Envoy Medical, Inc.

Envoy Medical, Inc. (Nasdaq: COCH) is a medical device company focused on hearing health, best known for developing the Acclaim Cochlear Implant, a fully implantable device targeting sensorineural hearing loss. The company entered public markets through a SPAC transaction with Anzu Special Acquisition Corp I, a blank-check vehicle sponsored by Anzu Partners that completed its initial public offering in 2021. On January 3, 2022, Envoy Medical submitted a Form 10-Q/A — an amendment to a previously filed quarterly report — with the SEC under accession number 0001104659-21-154834, reflecting a correction or update to prior period disclosures. Visit SpacDesk and sign up for full filing history, timeline data, and deal analytics on Envoy Medical and hundreds of other SPAC transactions.